Skip Navigation LinksIntegrated Review Groups > Risk, Prevention and Health Behavior IRG [RPHB] > Behavioral Medicine: Interventions and Outcomes Study Section [BMIO]

Behavioral Medicine: Interventions and Outcomes Study Section [BMIO]

The Behavioral Medicine: Interventions and Outcomes (BMIO) study section reviews behavioral, biobehavioral and alternative self-management approaches to medical/surgical treatment, and rehabilitation related to physical or non-psychiatric cognitive impairment as sequelae of cardiovascular diseases, asthma, arthritis, cancer or diabetes; and biobehavioral aspects of acute and chronic pain. Included are applications focused on interactions between experiential, behavioral, social, psychological, and physiological factors. BMIO reviews human studies across the age spectrum at the individual level.

Rosters

Topics

  • Cognitive, psychological, social and cultural factors affecting the experience and interpretation of pain or physical symptoms and their relationship to diagnosis or treatment of somatic diseases or conditions.
  • Psychological, behavioral or biological responses to interventions designed to reduce stress, distress or pain secondary to medical conditions or surgical procedures.
  • Behavioral interventions as primary or adjunctive treatments; studies of behavioral interventions designed to remedy or slow the progression of diseases or disorders.
  • Behavioral rehabilitation of neurological conditions associated with disability including cognitive, physical, communicative and social role functioning.
  • Outcome studies focused on changes in quality of life and psychosocial adjustment related to diseases or treatments.
  • Interactions between symptoms and health behavior change and management. Studies focusing on adherence, compliance, decision-making, self-care or self-management from the patient perspective.

Shared Interests and Overlaps

RPHB/ Psychosocial Risk and Disease Prevention (PRDP): BMIO and PRDP have a shared interest in disease prevention and intervention using behavioral methods across the spectrum. Applications focused on slowing/tracking the progression of diseases, mitigating complications, and reducing associated pain are reviewed in BMIO; applications focused on disease risk and prevention strategies, including cancer screening and obesity/weight reduction and treatment studies are reviewed in PRDP.

RPHB/ Interventions to Prevent and Treat Addictions (IPTA): BMIO and IPTA have a shared interest in behavioral pain management and use of opioids. Applications focused on psychosocial experience, interpretation of pain and quality of life, and normal use of opioids for pain management are reviewed in BMIO; applications focused on opioid addiction prevention, and treatment of opioid dependence are reviewed in IPTA.

BBBP/ Mechanisms of Emotion, Stress and Health (MESH): BMIO and MESH have a shared interest in stress and pain. Applications focused on behavioral, psychological, and social factors affecting the experience of pain as well as responses to interventions designed to reduce pain are reviewed in BMIO; applications focused more on the basic biological response to stress and pain, and in the interplay between stress/emotion and pain processes are reviewed in MESH. Applications focusing on sleep are also reviewed in MESH.

HDM/ Nursing and Related Clinical Sciences (NRCS): BMIO and NRCS have a shared interest in management of acute and chronic illnesses, including studies on management of symptoms, such as pain, fatigue and depression. Applications focused on behavioral methods of mitigating complications, improving treatment compliance and reducing associated pain are reviewed in BMIO; applications focused on provider-patient communication, caregiver issues, family illness management, and perinatal loss are reviewed in NRCS.

IFCN/ Somatosensory and Chemosensory Systems (SCS) - Somatosensory and Pain Systems (SPS): BMIO and SCS/SPS have a shared interest in pain studies. Applications focused on the interpretation and experience of pain and behavioral interventions designed to reduce pain secondary to disease are reviewed in BMIO; applications focused on the molecular biology, anatomy, physiology, psychophysics of pain, and somatosensory systems in humans and animals are reviewed in SCS/SPS. ​